{"id":308,"date":"2025-10-15T16:16:00","date_gmt":"2025-10-15T10:46:00","guid":{"rendered":"https:\/\/www.najao.com\/learn\/?p=308"},"modified":"2026-01-26T04:24:27","modified_gmt":"2026-01-25T22:54:27","slug":"autoimmune-disorders","status":"publish","type":"post","link":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/","title":{"rendered":"Autoimmune Disorders: When the Body Attacks Itself"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Introduction<\/h2>\n\n\n\n<p>Autoimmune disorders comprise a diverse collection of conditions in which the immune system erroneously targets and damages the body\u2019s own <a href=\"https:\/\/www.niehs.nih.gov\/health\/topics\/conditions\/autoimmune\" target=\"_blank\" rel=\"noreferrer noopener\">healthy cells<\/a>, tissues, or organs<strong><sup>1<\/sup><\/strong>. This triggers chronic inflammation and destruction, resulting in significant morbidity. Millions of people are affected by autoimmune diseases globally. An increasing prevalence is noted in women, with female-to-male ratios varying from 3:1 to as high as 9:1 in certain cases, which suggests hormonal and genetic influences<strong><sup>2<\/sup><\/strong>.<\/p>\n\n\n\n<p>In addition to the physical burden, autoimmune diseases often lead to chronic pain, fatigue, disability, and psychological distress, which severely affects the quality of life<strong><sup>3<\/sup><\/strong>. Economically, the complexity of these illnesses puts a substantial strain on healthcare systems and patients owing to the need for prolonged treatment and frequent disease monitoring<strong><sup>4<\/sup><\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology<\/h2>\n\n\n\n<p>Autoimmune diseases can be broadly divided into organ-specific and systemic disorders. Organ-specific autoimmune diseases cause immune damage that primarily affects a single tissue or organ. Examples include type 1 diabetes mellitus (T1DM), which targets pancreatic islet beta cells, and Hashimoto&#8217;s thyroiditis, which affects the thyroid gland<strong><sup>5, 6<\/sup><\/strong>. On the other hand, systemic autoimmune disorders include systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and scleroderma<strong><sup>7-9<\/sup><\/strong>. These impact several organ systems at once and produce complex clinical symptoms.<\/p>\n\n\n\n<p>Some patients have overlap syndromes, showing signs of multiple autoimmune diseases, which can complicate diagnosis and treatment.<\/p>\n\n\n\n<p>Autoimmune diseases often result from failed self-tolerance mechanisms, which normally prevent immune cells from attacking the body&#8217;s own tissues<strong><sup>10<\/sup><\/strong>. These disorders vary in terms of immune system targets, the mechanisms involved, and the degree of organ involvement.<\/p>\n\n\n\n<p>Two primary tolerance checkpoints are identified:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Central tolerance:<\/strong> In the primary lymphoid organs (the thymus for T cells and bone marrow for B cells), self-reactive lymphocyte clones are detected and removed during development<strong><sup>11<\/sup><\/strong>.<\/li>\n\n\n\n<li><strong>Peripheral tolerance:<\/strong> Self-reactive cells that are not eliminated centrally are suppressed or deactivated through mechanisms such as regulatory cells, inhibitory receptors, and other controls<strong><sup>11<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<p>Any failure in these tolerance mechanisms\u2014due to genetic, environmental, or immunological factors\u2014leads to the activation of autoreactive lymphocytes<strong><sup>12<\/sup><\/strong>. These lymphocytes then produce autoantibodies and pro-inflammatory cytokines that initiate and perpetuate tissue inflammation and damage.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Etiology and risk factors<\/h2>\n\n\n\n<p>Although the precise causes of autoimmune diseases remain partially understood, their development is influenced by a combination of environmental exposures, hormonal factors, genetic predisposition, and immune dysregulation<strong><sup>12<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Genetic predisposition<\/h3>\n\n\n\n<p>Certain human leukocyte antigen (HLA) alleles and non-HLA genes increase a person&#8217;s susceptibility to autoimmune diseases by influencing antigen presentation and the balance of the immune response. For example, HLA-DR3 and DR4 alleles are associated with T1DM and RA, respectively<strong><sup>13, 14<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Environmental triggers<\/h3>\n\n\n\n<p>Microbial infections (both viral and bacterial) may induce autoimmunity through mechanisms like molecular mimicry, epitope spreading, or by causing tissue damage that exposes hidden antigens<strong><sup>15<\/sup><\/strong>. Exposure to certain chemicals and medications can also trigger or worsen autoimmune responses<strong><sup>16, 17<\/sup><\/strong>. For example, exposure to ultraviolet radiation may intensify the dermatological symptoms of lupus, while tobacco use has been associated with an increased risk of RA and multiple sclerosis<strong><sup>18, 19<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Hormonal influences<\/h3>\n\n\n\n<p>Autoimmune disorders are more common in females, which indicates that sex hormones significantly influence immune function<strong><sup>20<\/sup><\/strong>. For instance, estrogens may enhance antibody-mediated immune responses, which can result in greater susceptibility<strong><sup>21<\/sup><\/strong>. Pregnancy and hormonal fluctuations often affect disease activity<strong><sup>22<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Immune dysregulation<\/h3>\n\n\n\n<p>Failures in regulatory T cell function, abnormal cytokine profiles (such as elevated type I interferons), and faulty immune checkpoints all contribute to persistent autoreactivity<strong><sup>23-25<\/sup><\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical Manifestations<\/h2>\n\n\n\n<p>Autoimmune diseases are characterized by a wide range of signs and symptoms, which vary according to the particular disorder and the organs affected.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Musculoskeletal<\/h3>\n\n\n\n<p>RA, one of the most common autoimmune diseases, is a classic example of inflammatory arthritis characterized by joint pain, swelling, stiffness, and reduced mobility<strong><sup>26<\/sup><\/strong>. Myalgia and muscle weakness are also frequently reported.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Endocrine<\/h3>\n\n\n\n<p>The autoimmune destruction or stimulation of endocrine glands causes conditions like Hashimoto\u2019s thyroiditis (hypothyroidism), Graves\u2019 disease (hyperthyroidism), Addison\u2019s disease (adrenal insufficiency), and T1DM (pancreatic beta-cell destruction)<strong><sup>5, 27-29<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Hematological<\/h3>\n\n\n\n<p>Autoimmune hemolytic anemia occurs when the immune system destroys red blood cells<strong><sup>30<\/sup><\/strong>. Similarly, immune suppression or destruction of white blood cells and platelets can cause leukopenia and thrombocytopenia<strong><sup>31<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Cardiovascular<\/h3>\n\n\n\n<p>Autoimmune diseases are associated with potential complications in the heart, such as ischemic injuries or cardiac failure<strong><sup>32<\/sup><\/strong>. Examples include inflammation of the heart, such as pericarditis and myocarditis, as well as inflammation of the blood vessels, known as vasculitis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Systemic symptoms<\/h3>\n\n\n\n<p>Common systemic symptoms include fatigue, fever, weight loss, malaise, and cutaneous manifestations like photosensitivity and vasculitic lesions<strong><sup>18, 33<\/sup><\/strong>. Rashes, such as the malar rash seen in lupus, are also common<strong><sup>34<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Neurological<\/h3>\n\n\n\n<p>This involves peripheral neuropathies and central nervous system disorders, such as multiple sclerosis<strong><sup>35<\/sup><\/strong>.<\/p>\n\n\n\n<p>A thorough clinical assessment, comprehensive history taking, and targeted laboratory investigations are critical for diagnosing autoimmune disorders. Diagnoses are frequently delayed due to the variability and nonspecific presentation of symptoms.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic approach<\/h2>\n\n\n\n<p>Diagnosis relies on clinical criteria combined with laboratory evidence of autoimmune activity:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Detection of specific autoantibodies, such as anti-nuclear antibodies, rheumatoid factor, and anti-thyroid antibodies<strong><sup>36-38<\/sup><\/strong>.<\/li>\n\n\n\n<li>Detection of inflammatory markers, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)<strong><sup>39, 40<\/sup><\/strong>.<\/li>\n\n\n\n<li>Imaging studies for organ involvement, such as joint X-rays and MRIs<strong><sup>41<\/sup><\/strong>.<\/li>\n\n\n\n<li>Biopsy in selected cases, such as the skin and kidney<strong><sup>41<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Treatment and management<\/h2>\n\n\n\n<p>Owing to the persistent and relapsing nature of autoimmune disorders, diagnosis and treatment are often lifelong. The aim of treatment is to suppress the aberrant immune response, control inflammation, and prevent irreversible organ damage. The goal is also to alleviate symptoms and improve a patient&#8217;s quality of life.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Pharmacological therapies<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Anti-inflammatory drugs:<\/strong> These include nonsteroidal anti-inflammatory drugs (NSAIDs), which are prescribed for mild pain and inflammation, and corticosteroids (e.g., prednisone), which are potent anti-inflammatory and immunosuppressive agents often used for acute flares or severe disease<strong><sup>42<\/sup><\/strong>.<\/li>\n\n\n\n<li><strong>Immunosuppressants:<\/strong> Traditional immunosuppressive drugs like methotrexate, azathioprine, and cyclosporine work by dampening the overall immune response<strong><sup>43<\/sup><\/strong>.<\/li>\n\n\n\n<li><strong>Biologic agents:<\/strong> This is a newer class of targeted therapies that specifically block certain molecules or cells involved in the autoimmune process, such as TNF inhibitors for RA or B-cell depleting agents for certain lymphomas and autoimmune conditions<strong><sup>42, 44<\/sup><\/strong>.<\/li>\n\n\n\n<li><strong>Disease-modifying antirheumatic drugs (DMARDs):<\/strong> This category includes some immunosuppressants and biologics that aim to slow disease progression and prevent joint damage in conditions like RA<strong><sup>42<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Non-pharmacological management<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Following certain <strong>lifestyle modifications<\/strong> such as a balanced diet, participating in regular and suitable physical activity, and using stress management methods may affect symptom levels and overall health<strong><sup>45<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Physical and occupational therapy <\/strong>are crucial for maintaining the mobility, strength, and function of joints and muscles<strong><sup>46<\/sup><\/strong>.<\/li>\n\n\n\n<li><strong>Pain management strategies<\/strong> may include over-the-counter pain relievers, topical treatments, or referral to pain specialists<strong><sup>47<\/sup><\/strong>.<\/li>\n\n\n\n<li><strong>Psychological counseling<\/strong> can help patients cope with the chronic nature of the disease and its impact on mental health<strong><sup>48<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<p>Effective management requires a multidisciplinary team approach with rheumatologists, endocrinologists, immunologists, and primary care providers collaborating closely.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis and future directions<\/h2>\n\n\n\n<p>Even with better diagnostics and treatments, mortality remains higher for patients with autoimmune diseases. Understanding immune tolerance failure, genetic and environmental factors, and new therapies is crucial to improving care and outcomes.<\/p>\n\n\n\n<p>Emerging research focuses on immunomodulation, <a href=\"https:\/\/www.najao.com\/learn\/precision-medicine\/\" target=\"_blank\" rel=\"noreferrer noopener\">personalized medicine<\/a>, biomarker discovery for early detection and prognosis, and novel therapeutic agents to comprehensively restore immune tolerance<strong><sup>49-52<\/sup><\/strong>.<\/p>\n\n\n\n<p>In summary, autoimmune diseases pose significant clinical and societal challenges due to their complex pathogenesis, diverse manifestations, and chronicity.<\/p>\n\n\n\n<!--nextpage-->\n\n\n\n<h2 class=\"wp-block-heading\">FAQs<\/h2>\n\n\n\n<h4 class=\"wp-block-heading\">1. Are autoimmune diseases contagious?<\/h4>\n\n\n\n<p>Autoimmune diseases are not contagious. They are caused by a malfunction in a person&#8217;s own immune system, not by external pathogens like viruses or bacteria. Therefore, they cannot be spread from person to person through contact or any other means.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">2. Can autoimmune diseases go into remission?<\/h4>\n\n\n\n<p>Yes, many autoimmune diseases can go into remission, a period where symptoms lessen or disappear and disease activity is minimal. Remission can occur spontaneously or as a result of treatment, but the disease is not cured and can return or &#8220;flare up&#8221; at any time.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">3. What is the difference between an autoimmune disease and an allergy?<\/h4>\n\n\n\n<p>An autoimmune disease occurs when the immune system mistakenly attacks the body&#8217;s own tissues. In contrast, an allergy is an overreaction to a harmless foreign substance. While both are abnormal immune responses, their targets differ: self-tissues for autoimmune diseases versus external triggers for allergies.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Reference<\/h2>\n\n\n\n<p>1. Pisetsky, D. S. (2023). Pathogenesis of autoimmune disease.&nbsp;<em>Nature Reviews Nephrology<\/em>,&nbsp;<em>19<\/em>(8), 509-524.<\/p>\n\n\n\n<p>2. Angum, F., Khan, T., Kaler, J., <em>et al<\/em>. (2020). The Prevalence of Autoimmune Disorders in Women: A Narrative Review.&nbsp;<em>Cureus<\/em>,&nbsp;<em>12<\/em>(5), e8094.<\/p>\n\n\n\n<p>3. Zielinski, M. R., Systrom, D. M., &amp; Rose, N. R. (2019). Fatigue, sleep, and autoimmune and related disorders.&nbsp;<em>Frontiers in immunology<\/em>,&nbsp;<em>10<\/em>, 1827.<\/p>\n\n\n\n<p>4. Miller, F. W. (2022). The Increasing Prevalence of Autoimmunity and Autoimmune Diseases: An Urgent Call to Action for Improved Understanding, Diagnosis, Treatment and Prevention.&nbsp;<em>Current opinion in immunology<\/em>,&nbsp;<em>80<\/em>, 102266.<\/p>\n\n\n\n<p>5. Powers, A. C. (2021). Type 1 diabetes mellitus: much progress, many opportunities.&nbsp;<em>The Journal of Clinical Investigation<\/em>,&nbsp;<em>131<\/em>(8), e142242.<\/p>\n\n\n\n<p>6. Zaletel, K., &amp; Gaberscek, S. (2011). Hashimoto&#8217;s thyroiditis: from genes to the disease.&nbsp;<em>Current genomics<\/em>,&nbsp;<em>12<\/em>(8), 576-588.<\/p>\n\n\n\n<p>7. Kuhn, A., Bonsmann, G., Anders, H. J., <em>et al<\/em>. (2015). The diagnosis and treatment of systemic lupus erythematosus.&nbsp;<em>Deutsches \u00c4rzteblatt International<\/em>,&nbsp;<em>112<\/em>(25), 423.<\/p>\n\n\n\n<p>8. Alivernini, S., Firestein, G. S., &amp; McInnes, I. B. (2022). The pathogenesis of rheumatoid arthritis.&nbsp;<em>Immunity<\/em>,&nbsp;<em>55<\/em>(12), 2255-2270.<\/p>\n\n\n\n<p>9. Rosendahl, A. H., Sch\u00f6nborn, K., &amp; Krieg, T. (2022). Pathophysiology of systemic sclerosis (scleroderma).&nbsp;<em>The Kaohsiung journal of medical sciences<\/em>,&nbsp;<em>38<\/em>(3), 187-195.<\/p>\n\n\n\n<p>10. Bolon, B. (2012). Cellular and molecular mechanisms of autoimmune disease.&nbsp;<em>Toxicologic pathology<\/em>,&nbsp;<em>40<\/em>(2), 216-229.<\/p>\n\n\n\n<p>11. Meng, X., Layhadi, J. A., Keane, S. T., <em>et al<\/em>. (2023). Immunological mechanisms of tolerance: Central, peripheral and the role of T and B cells.&nbsp;<em>Asia Pacific Allergy<\/em>,&nbsp;<em>13<\/em>(4), 175.<\/p>\n\n\n\n<p>12. Yasmeen, F., Pirzada, R. H., Ahmad, B., <em>et al<\/em>. (2024). Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies.&nbsp;<em>International Journal of Molecular Sciences<\/em>,&nbsp;<em>25<\/em>(14), 7666.<\/p>\n\n\n\n<p>13. Aydemir, \u00d6., Noble, J. A., Bailey, J. A., <em>et al<\/em>. (2019). Genetic variation within the HLA-DRA1 gene modulates susceptibility to type 1 diabetes in HLA-DR3 homozygotes.&nbsp;<em>Diabetes<\/em>,&nbsp;<em>68<\/em>(7), 1523-1527.<\/p>\n\n\n\n<p>14. Scholz, E., Mestre\u2010Ferrer, A., Daura, X., <em>et al<\/em>. (2016). A Comparative Analysis of the Peptide Repertoires of HLA\u2013DR Molecules Differentially Associated With Rheumatoid Arthritis.&nbsp;<em>Arthritis &amp; rheumatology<\/em>,&nbsp;<em>68<\/em>(10), 2412-2421.<\/p>\n\n\n\n<p>15. Suliman, B. A. (2024). Potential clinical implications of molecular mimicry\u2010induced autoimmunity.&nbsp;<em>Immunity, Inflammation and Disease<\/em>,&nbsp;<em>12<\/em>(2), e1178.<\/p>\n\n\n\n<p>16. Kosarek, N. N., &amp; Preston, E. V. (2024). Contributions of synthetic chemicals to autoimmune disease development and occurrence.&nbsp;<em>Current environmental health reports<\/em>,&nbsp;<em>11<\/em>(2), 128-144.<\/p>\n\n\n\n<p>17. Castiella, A., Zapata, E., Lucena, M. I., <em>et al<\/em>. (2014). Drug-induced autoimmune liver disease: a diagnostic dilemma of an increasingly reported disease.&nbsp;<em>World journal of hepatology<\/em>,&nbsp;<em>6<\/em>(4), 160.<\/p>\n\n\n\n<p>18. Kim, A., &amp; Chong, B. F. (2013). Photosensitivity in cutaneous lupus erythematosus.&nbsp;<em>Photodermatology, photoimmunology &amp; photomedicine<\/em>,&nbsp;<em>29<\/em>(1), 4-11.<\/p>\n\n\n\n<p>19. Baka, Z., Buz\u00e1s, E., &amp; Nagy, G. (2009). Rheumatoid arthritis and smoking: putting the pieces together.&nbsp;<em>Arthritis research &amp; therapy<\/em>,&nbsp;<em>11<\/em>(4), 238.<\/p>\n\n\n\n<p>20. Angum, F., Khan, T., Kaler, J., <em>et al<\/em>. (2020). The Prevalence of Autoimmune Disorders in Women: A Narrative Review.&nbsp;<em>Cureus<\/em>,&nbsp;<em>12<\/em>(5), e8094.<\/p>\n\n\n\n<p>21. Moulton, V. R. (2018). Sex hormones in acquired immunity and autoimmune disease.&nbsp;<em>Frontiers in immunology<\/em>,&nbsp;<em>9<\/em>, 2279.<\/p>\n\n\n\n<p>22. Piccinni, M. P., Lombardelli, L., Logiodice, F., <em>et al<\/em>. (2016). How pregnancy can affect autoimmune diseases progression?.&nbsp;<em>Clinical and Molecular Allergy<\/em>,&nbsp;<em>14<\/em>(1), 11.<\/p>\n\n\n\n<p>23. Buckner, J. H. (2010). Mechanisms of impaired regulation by CD4+ CD25+ FOXP3+ regulatory T cells in human autoimmune diseases.&nbsp;<em>Nature Reviews Immunology<\/em>,&nbsp;<em>10<\/em>(12), 849-859.<\/p>\n\n\n\n<p>24. Crow, M. K. (2010). Type I interferon in organ-targeted autoimmune and inflammatory diseases.&nbsp;<em>Arthritis research &amp; therapy<\/em>,&nbsp;<em>12<\/em>(Suppl 1), S5.<\/p>\n\n\n\n<p>25. Meffre, E., &amp; O&#8217;Connor, K. C. (2019). Impaired B\u2010cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.&nbsp;<em>Immunological reviews<\/em>,&nbsp;<em>292<\/em>(1), 90-101.<\/p>\n\n\n\n<p>26. Crincoli, V., Anelli, M. G., Quercia, E., <em>et al<\/em>. (2019). Temporomandibular disorders and oral features in early rheumatoid arthritis patients: an observational study.&nbsp;<em>International journal of medical sciences<\/em>,&nbsp;<em>16<\/em>(2), 253.<\/p>\n\n\n\n<p>27. Zaletel, K., &amp; Gaberscek, S. (2011). Hashimoto&#8217;s thyroiditis: from genes to the disease.&nbsp;<em>Current genomics<\/em>,&nbsp;<em>12<\/em>(8), 576-588.<\/p>\n\n\n\n<p>28. Grixti, L., Lane, L. C., &amp; Pearce, S. H. (2024). The genetics of Graves\u2019 disease.&nbsp;<em>Reviews in endocrine and metabolic disorders<\/em>,&nbsp;<em>25<\/em>(1), 203-214.<\/p>\n\n\n\n<p>29. Michels, A., &amp; Michels, N. (2014). Addison disease: early detection and treatment principles.&nbsp;<em>American family physician<\/em>,&nbsp;<em>89<\/em>(7), 563-568.<\/p>\n\n\n\n<p>30. Hill, A., &amp; Hill, Q. A. (2018). Autoimmune hemolytic anemia.&nbsp;<em>Hematology 2014, the American Society of Hematology Education Program Book<\/em>,&nbsp;<em>2018<\/em>(1), 382-389.<\/p>\n\n\n\n<p>31. Suwantarat, N., Tice, A. D., Khawcharoenporn, T., <em>et al<\/em>. (2010). Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment.&nbsp;<em>International journal of medical sciences<\/em>,&nbsp;<em>7<\/em>(1), 36.<\/p>\n\n\n\n<p>32. Pan, S. Y., Tian, H. M., Zhu, Y., <em>et al<\/em>. (2022). Cardiac damage in autoimmune diseases: Target organ involvement that cannot be ignored.&nbsp;<em>Frontiers in Immunology<\/em>,&nbsp;<em>13<\/em>, 1056400.<\/p>\n\n\n\n<p>33. Shanmugam, V. K., Angra, D., Rahimi, H., <em>et al<\/em>. (2017). Vasculitic and autoimmune wounds.&nbsp;<em>Journal of Vascular Surgery: Venous and Lymphatic Disorders<\/em>,&nbsp;<em>5<\/em>(2), 280-292.<\/p>\n\n\n\n<p>34. Uva, L., Miguel, D., Pinheiro, C., <em>et al<\/em>. (2012). Cutaneous manifestations of systemic lupus erythematosus.&nbsp;<em>Autoimmune diseases<\/em>,&nbsp;<em>2012<\/em>(1), 834291.<\/p>\n\n\n\n<p>35. Dobson, R., &amp; Giovannoni, G. (2019). Multiple sclerosis\u2013a review.&nbsp;<em>European journal of neurology<\/em>,&nbsp;<em>26<\/em>(1), 27-40.<\/p>\n\n\n\n<p>36. Andrade, L. E. C., Damoiseaux, J., Vergani, D., <em>et al<\/em>. (2022). Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases.&nbsp;<em>Journal of translational autoimmunity<\/em>,&nbsp;<em>5<\/em>, 100145.<\/p>\n\n\n\n<p>37. Motta, F., Bizzaro, N., Giavarina, D., <em>et al<\/em>. (2023). Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis.&nbsp;<em>RMD Open<\/em>,&nbsp;<em>9<\/em>(3), e002817.<\/p>\n\n\n\n<p>38. Fr\u00f6hlich, E., &amp; Wahl, R. (2017). Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases.&nbsp;<em>Frontiers in immunology<\/em>,&nbsp;<em>8<\/em>, 521.<\/p>\n\n\n\n<p>39. Haasnoot, A. J., van Tent-Hoeve, M., Wulffraat, N. M., <em>et al<\/em>. (2015). Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis.&nbsp;<em>American journal of ophthalmology<\/em>,&nbsp;<em>159<\/em>(2), 372-377.<\/p>\n\n\n\n<p>40. Abolhassani, A. R., Schuler, G., Kirchberger, M. C., <em>et al<\/em>. (2019). C-reactive protein as an early marker of immune-related adverse events.&nbsp;<em>Journal of Cancer Research and Clinical Oncology<\/em>,&nbsp;<em>145<\/em>(10), 2625-2631.<\/p>\n\n\n\n<p>41. Sargsyan, S. A., &amp; Thurman, J. M. (2012). Molecular imaging of autoimmune diseases and inflammation.&nbsp;<em>Molecular imaging<\/em>,&nbsp;<em>11<\/em>(3), 7290-2011.<\/p>\n\n\n\n<p>42. Li, P., Zheng, Y., &amp; Chen, X. (2017). Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics.&nbsp;<em>Frontiers in pharmacology<\/em>,&nbsp;<em>8<\/em>, 460.<\/p>\n\n\n\n<p>43. Kanatoula, D. D., Bodner, E., Ghoreschi, K., <em>et al<\/em>. (2024). Non\u2010biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases.&nbsp;<em>JDDG: Journal der Deutschen Dermatologischen Gesellschaft<\/em>,&nbsp;<em>22<\/em>(3), 400-421.<\/p>\n\n\n\n<p>44. Barnas, J. L., Looney, R. J., &amp; Anolik, J. H. (2019). B cell targeted therapies in autoimmune disease.&nbsp;<em>Current opinion in immunology<\/em>,&nbsp;<em>61<\/em>, 92-99.<\/p>\n\n\n\n<p>45. Pardali, E. C., Gkouvi, A., Gkouskou, K. K., <em>et al<\/em>. (2025). Autoimmune protocol diet: A personalized elimination diet for patients with autoimmune diseases.&nbsp;<em>Metabolism Open<\/em>,&nbsp;<em>25<\/em>, 100342.<\/p>\n\n\n\n<p>46. Gavin, J. P., Rossiter, L., Fenerty, V., <em>et al<\/em>. (2024). The Impact of Occupational Therapy on the Self\u2010Management of Rheumatoid Arthritis: A Mixed Methods Systematic Review.&nbsp;<em>ACR Open Rheumatology<\/em>,&nbsp;<em>6<\/em>(4), 214-249.<\/p>\n\n\n\n<p>47. Falasinnu, T., Lu, D., &amp; Baker, M. C. (2024). Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based study.&nbsp;<em>The Lancet Rheumatology<\/em>,&nbsp;<em>6<\/em>(8), e518-e527.<\/p>\n\n\n\n<p>48. Akyirem, S., Forbes, A., Wad, J. L., <em>et al<\/em>. (2022). Psychosocial interventions for adults with newly diagnosed chronic disease: a systematic review.&nbsp;<em>Journal of Health Psychology<\/em>,&nbsp;<em>27<\/em>(7), 1753-1782.<\/p>\n\n\n\n<p>49. Prendergast, G. C., Metz, R., Muller, A. J., <em>et al<\/em>. (2014). IDO2 in immunomodulation and autoimmune disease.&nbsp;<em>Frontiers in immunology<\/em>,&nbsp;<em>5<\/em>, 585.<\/p>\n\n\n\n<p>50. Tavakolpour, S., Darvishi, M., &amp; Ghasemiadl, M. (2018). Pharmacogenetics: a strategy for personalized medicine for autoimmune diseases.&nbsp;<em>Clinical genetics<\/em>,&nbsp;<em>93<\/em>(3), 481-497.<\/p>\n\n\n\n<p>51. Li, S., Song, G., Bai, Y., <em>et al<\/em>. (2021). Applications of protein microarrays in biomarker discovery for autoimmune diseases.&nbsp;<em>Frontiers in immunology<\/em>,&nbsp;<em>12<\/em>, 645632.<\/p>\n\n\n\n<p>52. Balogh, L., Ol\u00e1h, K., S\u00e1nta, S., <em>et al<\/em>. (2024). Novel and potential future therapeutic options in systemic autoimmune diseases.&nbsp;<em>Frontiers in immunology<\/em>,&nbsp;<em>15<\/em>, 1249500.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Autoimmune disorders are a group of conditions in which the immune system mistakenly attacks the body\u2019s own cells, tissues, or organs. This process can cause ongoing inflammation and tissue damage, leading to various health challenges. Autoimmune diseases impact millions of people worldwide.<\/p>\n","protected":false},"author":4,"featured_media":309,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,8,15,5],"tags":[],"coauthors":[12,9,10],"class_list":["post-308","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genetics","category-healthcare","category-immunology","category-microbiology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autoimmune Disorders: When the Body Attacks Itself<\/title>\n<meta name=\"description\" content=\"Autoimmune disorders are conditions in which the immune system erroneously targets and damages the body\u2019s own healthy cells, tissues, or organs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/\" \/>\n<link rel=\"next\" href=\"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autoimmune Disorders: When the Body Attacks Itself\" \/>\n<meta property=\"og:description\" content=\"Autoimmune disorders are conditions in which the immune system erroneously targets and damages the body\u2019s own healthy cells, tissues, or organs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"Najao Inovix\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/najaoinovix\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-15T10:46:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-25T22:54:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/11\/Autoimmune-Disorders.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2304\" \/>\n\t<meta property=\"og:image:height\" content=\"1728\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Moupriya Nag, Anwesha Acharyya, Sujay Ghosh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@najaoinovix\" \/>\n<meta name=\"twitter:site\" content=\"@najaoinovix\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moupriya Nag, Anwesha Acharyya, Sujay Ghosh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"13 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/\"},\"author\":{\"name\":\"Moupriya Nag\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/person\\\/2de98cae7fb5595934a293f82044cb3a\"},\"headline\":\"Autoimmune Disorders: When the Body Attacks Itself\",\"datePublished\":\"2025-10-15T10:46:00+00:00\",\"dateModified\":\"2026-01-25T22:54:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/\"},\"wordCount\":2587,\"publisher\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Autoimmune-Disorders.jpg\",\"articleSection\":[\"Genetics\",\"Healthcare\",\"Immunology\",\"Microbiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/\",\"name\":\"Autoimmune Disorders: When the Body Attacks Itself\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Autoimmune-Disorders.jpg\",\"datePublished\":\"2025-10-15T10:46:00+00:00\",\"dateModified\":\"2026-01-25T22:54:27+00:00\",\"description\":\"Autoimmune disorders are conditions in which the immune system erroneously targets and damages the body\u2019s own healthy cells, tissues, or organs.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/autoimmune-disorders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Autoimmune-Disorders.jpg\",\"contentUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Autoimmune-Disorders.jpg\",\"width\":2304,\"height\":1728,\"caption\":\"Autoimmune Disorders\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#website\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/\",\"name\":\"Najao Inovix\",\"description\":\"Cooperation for Success\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\",\"name\":\"Najao Inovix\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Najao-Favicon.png\",\"contentUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Najao-Favicon.png\",\"width\":2490,\"height\":2490,\"caption\":\"Najao Inovix\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/najaoinovix\\\/\",\"https:\\\/\\\/x.com\\\/najaoinovix\",\"https:\\\/\\\/www.instagram.com\\\/najaoinovix\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/najao\\\/\",\"https:\\\/\\\/www.threads.com\\\/@najaoinovix\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/person\\\/2de98cae7fb5595934a293f82044cb3a\",\"name\":\"Moupriya Nag\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2ccc0a2b775ff8b2d8bad5deb80f8e4d72a021d48d671584f60b051297caaab1?s=96&d=mm&r=gf8be39548251c0d06f6644e21d8b0e0d\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2ccc0a2b775ff8b2d8bad5deb80f8e4d72a021d48d671584f60b051297caaab1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2ccc0a2b775ff8b2d8bad5deb80f8e4d72a021d48d671584f60b051297caaab1?s=96&d=mm&r=g\",\"caption\":\"Moupriya Nag\"},\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/author\\\/moupriya\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autoimmune Disorders: When the Body Attacks Itself","description":"Autoimmune disorders are conditions in which the immune system erroneously targets and damages the body\u2019s own healthy cells, tissues, or organs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/","next":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/2\/","og_locale":"en_US","og_type":"article","og_title":"Autoimmune Disorders: When the Body Attacks Itself","og_description":"Autoimmune disorders are conditions in which the immune system erroneously targets and damages the body\u2019s own healthy cells, tissues, or organs.","og_url":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/","og_site_name":"Najao Inovix","article_publisher":"https:\/\/www.facebook.com\/najaoinovix\/","article_published_time":"2025-10-15T10:46:00+00:00","article_modified_time":"2026-01-25T22:54:27+00:00","og_image":[{"width":2304,"height":1728,"url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/11\/Autoimmune-Disorders.jpg","type":"image\/jpeg"}],"author":"Moupriya Nag, Anwesha Acharyya, Sujay Ghosh","twitter_card":"summary_large_image","twitter_creator":"@najaoinovix","twitter_site":"@najaoinovix","twitter_misc":{"Written by":"Moupriya Nag, Anwesha Acharyya, Sujay Ghosh","Est. reading time":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/#article","isPartOf":{"@id":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/"},"author":{"name":"Moupriya Nag","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/person\/2de98cae7fb5595934a293f82044cb3a"},"headline":"Autoimmune Disorders: When the Body Attacks Itself","datePublished":"2025-10-15T10:46:00+00:00","dateModified":"2026-01-25T22:54:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/"},"wordCount":2587,"publisher":{"@id":"https:\/\/www.najao.com\/learn\/#organization"},"image":{"@id":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/11\/Autoimmune-Disorders.jpg","articleSection":["Genetics","Healthcare","Immunology","Microbiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/","url":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/","name":"Autoimmune Disorders: When the Body Attacks Itself","isPartOf":{"@id":"https:\/\/www.najao.com\/learn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/#primaryimage"},"image":{"@id":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/11\/Autoimmune-Disorders.jpg","datePublished":"2025-10-15T10:46:00+00:00","dateModified":"2026-01-25T22:54:27+00:00","description":"Autoimmune disorders are conditions in which the immune system erroneously targets and damages the body\u2019s own healthy cells, tissues, or organs.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.najao.com\/learn\/autoimmune-disorders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.najao.com\/learn\/autoimmune-disorders\/#primaryimage","url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/11\/Autoimmune-Disorders.jpg","contentUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/11\/Autoimmune-Disorders.jpg","width":2304,"height":1728,"caption":"Autoimmune Disorders"},{"@type":"WebSite","@id":"https:\/\/www.najao.com\/learn\/#website","url":"https:\/\/www.najao.com\/learn\/","name":"Najao Inovix","description":"Cooperation for Success","publisher":{"@id":"https:\/\/www.najao.com\/learn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.najao.com\/learn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.najao.com\/learn\/#organization","name":"Najao Inovix","url":"https:\/\/www.najao.com\/learn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/logo\/image\/","url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/05\/Najao-Favicon.png","contentUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/05\/Najao-Favicon.png","width":2490,"height":2490,"caption":"Najao Inovix"},"image":{"@id":"https:\/\/www.najao.com\/learn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/najaoinovix\/","https:\/\/x.com\/najaoinovix","https:\/\/www.instagram.com\/najaoinovix\/","https:\/\/www.linkedin.com\/company\/najao\/","https:\/\/www.threads.com\/@najaoinovix"]},{"@type":"Person","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/person\/2de98cae7fb5595934a293f82044cb3a","name":"Moupriya Nag","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/2ccc0a2b775ff8b2d8bad5deb80f8e4d72a021d48d671584f60b051297caaab1?s=96&d=mm&r=gf8be39548251c0d06f6644e21d8b0e0d","url":"https:\/\/secure.gravatar.com\/avatar\/2ccc0a2b775ff8b2d8bad5deb80f8e4d72a021d48d671584f60b051297caaab1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2ccc0a2b775ff8b2d8bad5deb80f8e4d72a021d48d671584f60b051297caaab1?s=96&d=mm&r=g","caption":"Moupriya Nag"},"url":"https:\/\/www.najao.com\/learn\/author\/moupriya\/"}]}},"_links":{"self":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/comments?post=308"}],"version-history":[{"count":1,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/308\/revisions"}],"predecessor-version":[{"id":311,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/308\/revisions\/311"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/media\/309"}],"wp:attachment":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/media?parent=308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/categories?post=308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/tags?post=308"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/coauthors?post=308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}